Suchergebnisse - "*Mouth Neoplasms"

PubPharm (2.540)

51

Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Treatment for Recurrent Head and Neck Cancer : Phase I Trial of BAY 1895344 ATR Inhibitor Combined With Stereotactic Body Radiation Therapy and Pembrolizumab for Recurrent Head and Neck Squamous Cell Carcinoma

enthalten in: ClinicalTrials.gov | 2024

52

Integrated Cancer Repository for Cancer Research : Integrated Cancer Repository for Cancer Research

enthalten in: ClinicalTrials.gov | 2024

53

Oral carcinogenesis and non-invasive biomarkers for the diagnosis of oral squamous cell carcinoma

enthalten in: JPMA. The Journal of the Pakistan Medical Association | 2024

von Khan, S. | Alamgir, M.

54

Pharmacokinetic (PK) Analysis of Antitumor B in Patients With Oral Cancer : PK Analysis of Antitumor B in Patients With Oral Cancer

enthalten in: ClinicalTrials.gov | 2024

55

Salivary Biomarkers for Oral Cancer Detection : An Exploratory Systematic Review

enthalten in: International journal of molecular sciences | 2024

von Bastías, D. | Maturana, A. | Marín, C. | +2

56

Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer : Phase I/Ib Study of AKT Inhibitor Ipatasertib With Chemoradiation for Locally Advanced Head and Neck Cancer

enthalten in: ClinicalTrials.gov | 2024

57

The effect of the COVID-19 pandemic on the diagnosis and progression of oral cancer

enthalten in: International journal of oral and maxillofacial surgery | 2024

von Cwintal, M. | Shih, H. | Idrissi Janati, A. | +1

58

Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Treatment for Recurrent Head and Neck Cancer : Phase I Trial of BAY 1895344 ATR Inhibitor Combined With Stereotactic Body Radiation Therapy and Pembrolizumab for Recurrent Head and Neck Squamous Cell Carcinoma

enthalten in: ClinicalTrials.gov | 2024

59

Improving accuracy in nodal staging of oral cancer : Proposal of a new system

enthalten in: Surgical oncology | 2024

von Subramaniam, N. | Heller, G. | Clark, J. | +16

60

Carboplatin, Nab-Paclitaxel, Durvalumab Before Surgery and Adjuvant Therapy in Head and Neck Squamous Cell Carcinoma : Multimodality Therapy With Induction Carboplatin/Nab-Paclitaxel/Durvalumab Followed by Surgical Resection and Risk-adapted Adjuvant Therapy for the Treatment of Locally-Advanced and Surgically Resectable Squamous Cell Carcinoma of the Head and Neck

enthalten in: ClinicalTrials.gov | 2024